A nonparametric test for similarity of marginals-With applications to the assessment of population bioequivalence

Journal of Statistical Planning and Inference

Volumn 137, Issue 3, 2007, Pages 697-711

  Freitag, Gudrun ^a   Czado, Claudia ^b   Munk, Axel ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bioequivalence; Cross over trials; Hadamard derivative; Limit law; Multivariate empirical process; Pre post comparison

Indexed keywords

EID: 33750527339     PISSN: 03783758     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jspi.2006.06.003     Document Type: Article

References (56)

1. Bauer P., and Bauer M.M. Testing equivalence simultaneously for location and dispersion of two normally distributed populations. Biometrical J. 36 (1994) 643-660
2. Berger R.L., and Hsu J.C. Bioequivalence trials, intersection-union tests and equivalence confidence sets (with discussion). Statist. Sci. 11 (1996) 283-319
3. Bickel P., and Wichura M.J. Convergence criteria for multiparameter stochastic processes and some applications. Ann. Math. Statist. 42 (1971) 1656-1670
4. Chow S.-C. Individual bioequivalence-a review of the FDA draft guidance. Drug Inform. J. 33 (1999) 435-444
5. Chow S.-C., and Liu J.-P. Design and Analysis of Bioavailability and Bioequivalence Studies (1992), Marcel Dekker, New York
6. Chow S.-C., and Tse S.K. Outlier detection in bioavailability/bioequivalence studies. Statist. Med. 9 (1990) 549-558
7. CPMP (Committee for Proprietary Medicinal Products, Working Party on Efficacy of Medicinal Products), 1993. Draft Guideline: Biostatistical Methodology in Clinical Trials in Applications for Marketing Authorization for Medical Products.
8. CPMP (Committee for Proprietary Medicinal Products, Working Party on Efficacy of Medicinal Products), 2001. Note for Guidance on the Investigation of Bioavailability and Bioequivalence, July 2001.
9. Csörgö M., and Horvath L. Weighted Approximations in Probability and Statistics (1993), Wiley, Chichester
10. Csörgö M., and Révész P. Strong Approximations in Probability and Statistics (1981), Academic Press, New York
11. Czado C., and Munk A. Bootstrap methods for the nonparametric assessment of population bioequivalence and similarity of distributions. J. Statist. Comput. Simulation 68 (2001) 243-280
12. 2-Wasserstein distance. Ann. Statist. 27 (1999) 1230-1239
13. del Barrio E., Giné E., and Matrán C. Central limit theorems for the Wasserstein distance between the empirical and the true distributions. Ann. Probab. 27 (1999) 1009-1071
14. del Barrio E., Cuesta-Albertos J.A., and Matrán C. Contributions of empirical and quantile processes to the asymptotic theory of goodness-of-fit tests. Test 9 (2000) 1-96 (with comments)
15. Dobrushin R.L. Describing a system of random variables by conditional distributions. Theory Probab. Appl. 15 (1970) 458-486
16. Efron B., and Tibshirani R.J. An Introduction to the Bootstrap (1993), Chapman & Hall, London
17. FDA (Food and Drug Administration), 1992. Guidance on Statistical Procedures for Bioequivalence Studies using a Standard Two-Treatment Crossover Design. Office of Generic Drugs, Rockville, MD, July 1992.
18. FDA (Food and Drug Administration), 2001. Guidance for industry: statistical approaches to establishing bioequivalence. US Department of Health and Human Services, Center for Drug Evaluation and Research, January 2001.
19. FDA (Food and Drug Administration) 2003. Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products-general considerations. US Department of Health and Human Services, Center for Drug Evaluation and Research, March 2003.
20. Freeman P.R. The performance of the two-stage analysis of two-treatment, two-period crossover trials. Statist. Med. 8 (1989) 1421-1432
21. Freitag G., Munk A., and Hoffmann K. Vergleich zweier Messmethoden mit einem Goldstandard am Beispiel der 20 MHz-Sonographie und der klinischen Palpation zur Dickenbestimmung von pigmentierten Tumoren der Haut. Ultrasch. Med. 24 (2003) 184-189
22. Freitag G., Munk A., and Vogt M. Assessing structural relationships between distributions-a quantile process approach based on Mallows distance. In: Akritas M.G., and Politis D.N. (Eds). Recent Advances and Trends in Nonparametric Statistics (2003), Elsevier Science B.V., Amsterdam
23. Gill R. Non- and semi-parametric maximum likelihood estimators and the von Mises method (part 1). Scand. J. Statist. 16 (1989) 97-128
24. Gould A.L. Discussion of individual bioequivalence by M.L. Chen. J. Biopharm. Statist. 7 (1997) 23-31
25. Gould A.L. A practical approach for evaluating population and individual bioequivalence. Statist. Med. 19 (2000) 2721-2740
26. Govindarajulu Z. A class of asymptotically distribution free test procedures for equality of marginals under multivariate dependence. Amer. J. Math. Management Sci. 15 (1995) 375-394
27. Govindarajulu Z. A class of asymptotically distribution free tests for equality of marginals in multivariate populations. Math. Methods Statist. 6 (1997) 92-111
28. Guilbauld O. Exact inferences about the within subject variability in 2 × 2 crossover trials. J. Amer. Statist. Assoc. 88 (1993) 939-946
29. Hauck W.W., and Anderson S. Types of bioequivalence and related statistical considerations. Internat. J. Clin. Pharmacol. Ther. Toxic. 30 (1992) 181-187
30. Hauck W.W., Bois F.Y., Hyslop T., Gee L., and Anderson S. A parametric approach to population bioequivalence. Statist. Med. 16 (1997) 441-454
31. Hauschke D., and Steinijans V.W. The U.S. draft guidance regarding population and individual bioequivalence approaches: comments by a research-based pharmaceutical company. Statist. Med. 19 (2000) 2769-2774
32. Hauschke D., Steinijans V.W., and Diletti E. A distribution-free procedure for the statistical analysis of bioequivalence studies. Internat. J. Clin. Pharmacol. Ther. Toxic. 28 (1990) 72-78
33. Hauschke D., Steinijans V., and Hothorn L.A. A note on Welch's approximate t-solution to bioequivalence assessment. Biometrika 83 (1997) 236-237
34. Holder D.J., and Hsuan F. Moment-based criteria for determining bioequivalence. Biometrika 80 (1993) 835-846
35. Janssen A. Nonparametric bioequivalence tests for statistical functionals and their efficient power functions. Statist. Decision 18 (2000) 49-78
36. Jones B., and Kenward M.G. Design and Analysis of Cross-over Trials (1988), Chapman & Hall, London
37. Lee Y., Shao J., and Chow S.-C. Modified large-sample confidence intervals for linear combinations of variance components: estimation, theory, and application. J. Amer. Statist. Assoc. 99 (2004) 467-478
38. Liu J.P., and Weng C.S. Detection of outlying data in bioavailability/bioequivalence studies. Statist. Med. 10 (1991) 1375-1389
39. Mallows C.L. A note on asymptotic joint normality. Ann. Math. Statist. 43 (1972) 508-515
40. Munk A. Equivalence and interval testing for Lehmann's alternative. J. Amer. Statist. Assoc. 91 (1996) 1187-1197
41. Munk A., and Czado C. Nonparametric validation of similar distributions and assessment of goodness of fit. J. Roy. Statist. Soc. Ser. B 60 (1998) 223-241
42. Podgor M.J., and Gastwirth J.L. Efficiency robust rank tests for stratified data. In: Brunner E., and Denker M. (Eds). Research Developments in Probability and Statistics. Festschrift in honor of Madan L. Puri (1996), VSP International Science Publishers
43. 2-distance. J. Multivariate Anal. 32 (1990) 48-54
44. Schall R. Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar. Biometrics 51 (1995) 615-626
45. Schall R., and Luus H.G. On population and individual bioequivalence. Statist. Med. 12 (1993) 1109-1124
46. Schuirmann D.J. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacok. Biopharm. 15 (1987) 657-680
47. Senn S. Cross-Over Trials in Clinical Research (1993), Wiley, New York
48. Shao J., Kübler J., and Pigeot I. Consistency of the bootstrap procedure in individual bioequivalence. Biometrika 87 (2000) 573-585
49. Sheiner L.B. Bioequivalence revisited. Statist. Med. 11 (1992) 1777-1788
50. Steland A. Bootstrapping rank statistics. Metrika 47 (1998) 251-297
51. van der Vaart A., and Wellner J. Weak Convergence and Empirical Processes-With Applications to Statistics (1996), Springer, New York
52. Vonesh E.F., and Chinchilli V.M. Linear and Nonlinear Models for the Analysis of Repeated Measurements (1997), Marcel Dekker Inc., New York
53. Wang W. Optimal unbiased tests for equivalence in intrasubject variability. J. Amer. Statist. Assoc. 92 (1997) 163-1170
54. Wellek S. A new approach to equivalence assessment in standard comparative bioequivalence trials by means of the Mann-Whitney statistics. Biometrical J. 38 (1996) 695-710
55. Wellek S. Bayesian construction of an improved parametric test for probability-based individual bioequivalence. Biometrical J. 42 (2000) 1039-1052
56. Wellek S. On a reasonable disaggregate criterion of population bioequivalence admitting of resampling-free testing procedures. Statist. Med. 19 (2000) 2755-2767